Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS)

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Myong Cheol Lim, Ji Hyun Kim, B. K. Park, Jaekyung Bae, Jung-Yun Lee, Heon Jong Yoo, Yun Hwan Kim, Ga Won Yim, Jae Yun Song, Yong Jung Song, Suk‐Joon Chang, Dae Hoon Jeong
+7 more Dae-Yeon Kim, Jeong-Yeol PARK, Ki Hyung Kim, Ju-Won Roh, Jae Kwan Lee, Sang‐Soo Seo, Sang‐Yoon Park
DOI: 10.1016/j.ijgc.2025.103203
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Intraperitoneal and Appendiceal Malignancies PARP inhibition in cancer therapy

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103203–103203
Publication date
1 February 2026
Language
EN